Please enable JavaScript to continue using this application.

Compare $DNTH vs $TNGX | Chartloom

Compare

$DNTH vs $TNGX

Dianthus Therapeutics Inc · Tango Therapeutics Inc

DNTH

Dianthus Therapeutics Inc

TNGX

Tango Therapeutics Inc

Compare $DNTH vs $TNGX

Comparing Dianthus Therapeutics Inc and Tango Therapeutics Inc

DNTHDianthus Therapeutics Inc

TNGXTango Therapeutics Inc

DNTHDianthus Therapeutics Inc

Market cap

$4.50B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3,009.80x

Rev growth (TTM)

-60.8%

YTD performance

107.6%

52W performance

137.0%

FCF yield

-3.5%

TNGXTango Therapeutics Inc

Market cap

$3.87B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

121.5%

YTD performance

166.6%

52W performance

244.6%

FCF yield

-3.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DNTH

TNGX

Detailed metrics comparison

DNTH

Dianthus Therapeutics Inc

TNGX

Tango Therapeutics Inc

Market Cap

DNTH$4.50B

TNGX$3.87B

Enterprise Value

DNTH$4.39B

TNGX$3.52B

Price

DNTH$82.37

TNGX$23.81

P/E Ratio

DNTHN/A

TNGXN/A

P/S Ratio

DNTH2,365.11x

TNGX71.83x

EV/Sales

DNTH2,307.05x

TNGX65.41x

EV/EBITDA

DNTH0.00x

TNGX0.00x

P/B Ratio

DNTH4.21x

TNGX3.82x

P/FCF Ratio

DNTHN/A

TNGXN/A

EV/FCF

DNTH-28.21x

TNGX-24.40x

PEG Ratio

DNTHN/A

TNGXN/A

Forward P/E (NTM)

DNTHN/A

TNGXN/A

Forward P/S (NTM)

DNTH3,009.80x

TNGXN/A

Revenue (TTM)

DNTH$2M

TNGX$54M

Revenue Growth (YoY)

DNTH-60.8%

TNGX121.5%

Forward Rev Growth

DNTH-5.4%

TNGX732.8%

Gross Margin (TTM)

DNTH0.0%

TNGX0.0%

Operating Margin (TTM)

DNTH0.0%

TNGX0.0%

EBITDA Margin (TTM)

DNTH-11434.9%

TNGX-249.8%

Net Margin (TTM)

DNTH-10097.0%

TNGX-229.9%

FCF Margin (TTM)

DNTH-8178.0%

TNGX-268.1%

Net Income (TTM)

DNTH$-192M

TNGX$-124M

FCF (TTM)

DNTH$-156M

TNGX$-144M

EPS (TTM)

DNTH-$3.43

TNGX-$0.83

ROE (TTM)

DNTH-2253.0%

TNGX-2574.0%

ROA (TTM)

DNTH-2155.0%

TNGX-2336.0%

ROIC (TTM)

DNTH-2253.0%

TNGX-2574.0%

Cash

DNTH$111M

TNGX$346M

Debt

DNTH$0

TNGX$0

Net Cash/Debt

DNTH$111M

TNGX$346M

Current Ratio (TTM)

DNTH26.10x

TNGX50.82x

Quick Ratio (TTM)

DNTH25.80x

TNGX49.95x

Debt/Equity (TTM)

DNTH0.00x

TNGX0.00x

Debt/Assets (TTM)

DNTH0.0%

TNGX0.0%

Interest Coverage (TTM)

DNTHN/A

TNGXN/A

Net Debt/EBITDA (TTM)

DNTH0.00x

TNGX0.00x

Beta

DNTH1.99

TNGX1.18

52W Performance

DNTH137.0%

TNGX244.6%

YTD Performance

DNTH107.6%

TNGX166.6%

% from 52W High

DNTH-30.1%

TNGX-30.8%

% from 52W Low

DNTH155.6%

TNGX255.9%

Asset Turnover (TTM)

DNTH0.00x

TNGX0.26x

FCF Yield (TTM)

DNTH-3.5%

TNGX-3.7%

Earnings Yield (TTM)

DNTH-4.3%

TNGX-3.2%

Dividend Yield (TTM)

DNTHN/A

TNGXN/A

Rule of 40

DNTH-8,238.8

TNGX-146.6

EV/GP/RG

DNTHN/A

TNGXN/A

Ticker research

View DNTH research View TNGX research

Metric	DNTH Dianthus Therapeutics Inc	TNGX Tango Therapeutics Inc
Market & Valuation
Market Cap	$4.50B	$3.87B
Enterprise Value	$4.39B	$3.52B
Price	$82.37	$23.81
P/E Ratio	N/A	N/A
P/S Ratio	2,365.11x	71.83x
EV/Sales	2,307.05x	65.41x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.21x	3.82x
P/FCF Ratio	N/A	N/A
EV/FCF	-28.21x	-24.40x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3,009.80x	N/A
Revenue & Growth
Revenue (TTM)	$2M	$54M
Revenue Growth (YoY)	-60.8%	121.5%
Forward Rev Growth	-5.4%	732.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-11434.9%	-249.8%
Net Margin (TTM)	-10097.0%	-229.9%
FCF Margin (TTM)	-8178.0%	-268.1%
Net Income (TTM)	$-192M	$-124M
FCF (TTM)	$-156M	$-144M
EPS (TTM)	-$3.43	-$0.83
ROE (TTM)	-2253.0%	-2574.0%
ROA (TTM)	-2155.0%	-2336.0%
ROIC (TTM)	-2253.0%	-2574.0%
Financial Health
Cash	$111M	$346M
Debt	$0	$0
Net Cash/Debt	$111M	$346M
Current Ratio (TTM)	26.10x	50.82x
Quick Ratio (TTM)	25.80x	49.95x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.99	1.18
52W Performance	137.0%	244.6%
YTD Performance	107.6%	166.6%
% from 52W High	-30.1%	-30.8%
% from 52W Low	155.6%	255.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.26x
FCF Yield (TTM)	-3.5%	-3.7%
Earnings Yield (TTM)	-4.3%	-3.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,238.8	-146.6
EV/GP/RG	N/A	N/A
Ticker research	View DNTH research	View TNGX research

Valuation

P/S Ratio

TNGX

71.83x

DNTH

2,365.11x

EV/FCF

DNTH

-28.21x

TNGX

-24.40x

Growth & revenue

Revenue Growth TTM

TNGX

121.5%

DNTH

-60.8%

Forward Revenue Growth

TNGX

732.8%

DNTH

-5.4%

Profitability & performance

Gross Margin

DNTH

0.0%

TNGX

0.0%

ROE

DNTH

-2253.0%

TNGX

-2574.0%

FCF Yield %

DNTH

-3.5%

TNGX

-3.7%

52-Week Performance

TNGX

244.6%

DNTH

137.0%

Detailed metrics comparison

DNTH

Dianthus Therapeutics Inc

TNGX

Tango Therapeutics Inc

Market Cap

DNTH$4.50B

TNGX$3.87B

Enterprise Value

DNTH$4.39B

TNGX$3.52B

Price

DNTH$82.37

TNGX$23.81

P/E Ratio

DNTHN/A

TNGXN/A

P/S Ratio

DNTH2,365.11x

TNGX71.83x

EV/Sales

DNTH2,307.05x

TNGX65.41x

EV/EBITDA

DNTH0.00x

TNGX0.00x

P/B Ratio

DNTH4.21x

TNGX3.82x

P/FCF Ratio

DNTHN/A

TNGXN/A

EV/FCF

DNTH-28.21x

TNGX-24.40x

PEG Ratio

DNTHN/A

TNGXN/A

Forward P/E (NTM)

DNTHN/A

TNGXN/A

Forward P/S (NTM)

DNTH3,009.80x

TNGXN/A

Revenue (TTM)

DNTH$2M

TNGX$54M

Revenue Growth (YoY)

DNTH-60.8%

TNGX121.5%

Forward Rev Growth

DNTH-5.4%

TNGX732.8%

Gross Margin (TTM)

DNTH0.0%

TNGX0.0%

Operating Margin (TTM)

DNTH0.0%

TNGX0.0%

EBITDA Margin (TTM)

DNTH-11434.9%

TNGX-249.8%

Net Margin (TTM)

DNTH-10097.0%

TNGX-229.9%

FCF Margin (TTM)

DNTH-8178.0%

TNGX-268.1%

Net Income (TTM)

DNTH$-192M

TNGX$-124M

FCF (TTM)

DNTH$-156M

TNGX$-144M

EPS (TTM)

DNTH-$3.43

TNGX-$0.83

ROE (TTM)

DNTH-2253.0%

TNGX-2574.0%

ROA (TTM)

DNTH-2155.0%

TNGX-2336.0%

ROIC (TTM)

DNTH-2253.0%

TNGX-2574.0%

Cash

DNTH$111M

TNGX$346M

Debt

DNTH$0

TNGX$0

Net Cash/Debt

DNTH$111M

TNGX$346M

Current Ratio (TTM)

DNTH26.10x

TNGX50.82x

Quick Ratio (TTM)

DNTH25.80x

TNGX49.95x

Debt/Equity (TTM)

DNTH0.00x

TNGX0.00x

Debt/Assets (TTM)

DNTH0.0%

TNGX0.0%

Interest Coverage (TTM)

DNTHN/A

TNGXN/A

Net Debt/EBITDA (TTM)

DNTH0.00x

TNGX0.00x

Beta

DNTH1.99

TNGX1.18

52W Performance

DNTH137.0%

TNGX244.6%

YTD Performance

DNTH107.6%

TNGX166.6%

% from 52W High

DNTH-30.1%

TNGX-30.8%

% from 52W Low

DNTH155.6%

TNGX255.9%

Asset Turnover (TTM)

DNTH0.00x

TNGX0.26x

FCF Yield (TTM)

DNTH-3.5%

TNGX-3.7%

Earnings Yield (TTM)

DNTH-4.3%

TNGX-3.2%

Dividend Yield (TTM)

DNTHN/A

TNGXN/A

Rule of 40

DNTH-8,238.8

TNGX-146.6

EV/GP/RG

DNTHN/A

TNGXN/A

Ticker research

View DNTH research View TNGX research

Metric	DNTH Dianthus Therapeutics Inc	TNGX Tango Therapeutics Inc
Market & Valuation
Market Cap	$4.50B	$3.87B
Enterprise Value	$4.39B	$3.52B
Price	$82.37	$23.81
P/E Ratio	N/A	N/A
P/S Ratio	2,365.11x	71.83x
EV/Sales	2,307.05x	65.41x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.21x	3.82x
P/FCF Ratio	N/A	N/A
EV/FCF	-28.21x	-24.40x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3,009.80x	N/A
Revenue & Growth
Revenue (TTM)	$2M	$54M
Revenue Growth (YoY)	-60.8%	121.5%
Forward Rev Growth	-5.4%	732.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-11434.9%	-249.8%
Net Margin (TTM)	-10097.0%	-229.9%
FCF Margin (TTM)	-8178.0%	-268.1%
Net Income (TTM)	$-192M	$-124M
FCF (TTM)	$-156M	$-144M
EPS (TTM)	-$3.43	-$0.83
ROE (TTM)	-2253.0%	-2574.0%
ROA (TTM)	-2155.0%	-2336.0%
ROIC (TTM)	-2253.0%	-2574.0%
Financial Health
Cash	$111M	$346M
Debt	$0	$0
Net Cash/Debt	$111M	$346M
Current Ratio (TTM)	26.10x	50.82x
Quick Ratio (TTM)	25.80x	49.95x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.99	1.18
52W Performance	137.0%	244.6%
YTD Performance	107.6%	166.6%
% from 52W High	-30.1%	-30.8%
% from 52W Low	155.6%	255.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.26x
FCF Yield (TTM)	-3.5%	-3.7%
Earnings Yield (TTM)	-4.3%	-3.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,238.8	-146.6
EV/GP/RG	N/A	N/A
Ticker research	View DNTH research	View TNGX research